Alzheimer's may affect the brain differently in African-Americans than European-Americans

July 15, 2015, American Academy of Neurology

Alzheimer's disease may cause different changes in the brain, or pathologies, in African-Americans than in white Americans of European descent, according to a study published in the July 15, 2015, online issue of the medical journal of the American Academy of Neurology.

"Because some studies suggest that Alzheimer's disease is more common among older African-Americans than European-Americans, we wanted to see whether the brain changes caused by Alzheimer's are different in these two racial groups," said study author Lisa L. Barnes, PhD, with Rush University Medical Center in Chicago. "Studying how Alzheimer's disease looks in the brain in individuals of different races may help us to further understand the disease and pinpoint strategies for prevention and treatment."

The study included 41 African-Americans with a clinical diagnosis of Alzheimer's dementia from the memory clinic, who had an autopsy of their brain performed after death. They were then compared to 81 deceased European-Americans who had Alzheimer's dementia with the same level of disease severity and were of the same age, sex and education level. Researchers looked for typical signs of Alzheimer's disease (plaques and tangles) as well as other brain changes that can cause dementia, such as infarcts (the associated with stroke) and Lewy bodies (associated with Lewy body or Parkinson'disease). They noted whether people had just one pathology or more than one. They also looked at small and large blood vessel disease.

Almost all participants in the study had Alzheimer's disease in their brain. Only about half of the European-Americans had pure Alzheimer's disease pathology (no additional pathologies contributing to dementia) whereas the rest had Alzheimer's disease pathology with either infarcts or Lewy bodies. In contrast, less than 25 percent of the African Americans had pure Alzheimer's disease pathology. On the other hand, almost three-quarters (71 percent) of African-Americans had Alzheimer's disease pathology mixed with another type of pathology, compared to 51 percent of European-Americans. Clinical Alzheimer's disease in African-Americans was much more likely to involve pathologies other than Alzheimer's . African-Americans also had more frequent and severe .

"Our study has important clinical implications because it may suggest a need for different types of Alzheimer's prevention and treatments in African-Americans. Indeed, current Alzheimer's drugs primarily target specific Alzheimer pathologies in the . Given the mixed pattern of disease that we see in African American brains, it will be important to develop new treatments that target these other common pathologies, particularly for African-Americans," said Barnes.

Explore further: Researchers identify potential gene that may increase risk of ad in African Americans

Related Stories

Researchers identify potential gene that may increase risk of ad in African Americans

August 4, 2014
Researchers from Boston University School of Medicine (BUSM) report that two rare variants in the AKAP9 gene significantly increase the risk of Alzheimer's disease (AD) in African-Americans.

Alzheimer's disease may be more prevalent and manifests itself differently among African-Americans

April 7, 2014
A new study by researchers at Rush University Medical Center reviews research that suggests that the risk for developing Alzheimer's disease among older African Americans may be two to three times greater than in the non-Hispanic ...

Memory, thinking tests may hint at Alzheimer's risk

June 24, 2015
(HealthDay)—Mistakes made on memory and thinking tests may be early warning signs of Alzheimer's disease, researchers report.

Skin test may shed new light on Alzheimer's and Parkinson's diseases

February 24, 2015
Scientists have discovered a skin test that may shed new light on Alzheimer's and Parkinson's diseases, according to a study released today will be presented at the American Academy of Neurology's 67th Annual Meeting in Washington, ...

Neurogeneticists harness immune cells to clear Alzheimer's-associated plaques

February 5, 2015
New research from scientists at the Keck School of Medicine of the University of Southern California (USC) shows that the body's immune system may be able to clear the brain of toxic plaque build-up that is the hallmark of ...

Two parents with Alzheimer's disease? Disease may show up decades early on brain scans

February 12, 2014
People who are dementia-free but have two parents with Alzheimer's disease may show signs of the disease on brain scans decades before symptoms appear, according to a new study published in the February 12, 2014, online issue ...

Recommended for you

Does diabetes damage brain health?

December 14, 2018
(HealthDay)—Diabetes has been tied to a number of complications such as kidney disease, but new research has found that older people with type 2 diabetes can also have more difficulties with thinking and memory.

Amyloid pathology transmission in lab mice and historic medical treatments

December 13, 2018
A UCL-led study has confirmed that some vials of a hormone used in discontinued medical treatments contained seeds of a protein implicated in Alzheimer's disease, and are able to seed amyloid pathology in mice.

Study links slowed brainwaves to early signs of dementia

December 13, 2018
To turn back the clock on Alzheimer's disease, many researchers are seeking ways to effectively diagnose the neurodegenerative disorder earlier.

New discoveries predict ability to forecast dementia from single molecule

December 11, 2018
Scientists who recently identified the molecular start of Alzheimer's disease have used that finding to determine that it should be possible to forecast which type of dementia will develop over time—a form of personalized ...

Researchers classify Alzheimer's patients in six subgroups

December 5, 2018
Researchers studying Alzheimer's disease have created an approach to classify patients with Alzheimer's disease, a finding that may open the door for personalized treatments.

Neuroscientists pinpoint genes tied to dementia

December 3, 2018
A UCLA-led research team has identified genetic processes involved in the neurodegeneration that occurs in dementia—an important step on the path toward developing therapies that could slow or halt the course of the disease. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.